Scott Gabbard MD
Esophagus Disease, Gastrointestinal Functional & Motility Disorders
Associate Staff
Join to View Full Profile
9500 Euclid AveCleveland Clinic Department Of GastroenterologyCleveland, OH 44195
Phone+1 216-444-6536
Fax+1 603-650-5225
Dr. Gabbard is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Scott Gabbard is a gastroenterologist in Cleveland, OH. He received his medical degree from Case Western Reserve University School of Medicine and has been in practice 11 years. He specializes in esophagus disease and gastrointestinal functional & motility disorders and is experienced in general gastroenterology, esophageal disease, gastrointestinal functional disorders, gastrointestinal motility disorders, and bariatric medicine.
Education & Training
Dartmouth-Hitchcock/Mary Hitchcock Memorial HospitalFellowship, Gastroenterology, 2009 - 2012
University of North Carolina HospitalsResidency, Internal Medicine, 2006 - 2009
Case Western Reserve University School of MedicineClass of 2006
Certifications & Licensure
NH State Medical License 2012 - Present
OH State Medical License 2013 - 2027
American Board of Internal Medicine Gastroenterology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
Clinical Trials
- Treatment Use of Domperidone for Gastroparesis
- Applying Nutrient Drink Test in Understanding Pathophysiology of CVS Start of enrollment: 2018 Feb 01
Publications & Presentations
PubMed
- Systematic Review: Variability in Definitions of Fibrostenosis in Eosinophilic Oesophagitis.Claire A Beveridge, Natalie Farha, Christina Hermanns, Chiara Maruggi, Katherine Falloon
Alimentary Pharmacology & Therapeutics. 2025-08-01 - Heller myotomy for esophageal achalasia: Outcomes in 1010 patients with longitudinal follow-up.John O Barron, Andrew J Toth, Eugene H Blackstone, Sadhvika Ramji, Nethra Jain
The Journal of Thoracic and Cardiovascular Surgery. 2025-06-18 - A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Metopimazine Mesylate (NG101) in Participants With Gastroparesis.Jack Loesch, Eyad Hamza, Pankaj J Pasricha, Judy Nee, Michael Cline
The American Journal of Gastroenterology. 2025-05-14
Authored Content
- Tu1157 COMPARISON OF OUTCOMES OF PERORAL ENDOSCOPIC MYOTOMY (POEM) IN ACHALASIA PATIENTS WITH OR WITHOUT PRIOR LAPROSCOPIC HELLER'S MYOTOMY (LHM)May 2018
- Tu1157 COMPARISON OF OUTCOMES OF PERORAL ENDOSCOPIC MYOTOMY (POEM) IN ACHALASIA PATIENTS WITH OR WITHOUT PRIOR LAPROSCOPIC HELLER'S MYOTOMY (LHM)May 2018
Press Mentions
Navigating Esophageal Dysfunction in Immune and Infectious Disorders: AGA Clinical Practice UpdateFebruary 19th, 2025- GERD Awareness Week: FDA News, Endoscopic Fundoplication, Laparoscopic SurgeryNovember 26th, 2022
- Is FDA Approval in Sight for Emerging EoE Therapies?March 22nd, 2022
- Join now to see all
Grant Support
- ACG Pilot GrantAmerican College of Gastroenterology2016–2017
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
